Appointment booking for Dr. Anna Gramling, MD is currently not available.Dr. Anna Gramling, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Anna Gramling, MD (she/her) is a Rheumatologist in Plainfield, IN with over 16 years of experience. What is your opinion of Dr. Anna Gramling, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Anna Gramling, MD has received over $9,068 which includes payments from the following companies:
$2,023.01 from Amgen Inc.
$1,137.75 from Novartis Pharmaceuticals Corporation
$1,014.65 from AbbVie, Inc.
$982.06 from Pfizer Inc.
$626.79 from Janssen Biotech, Inc.
$623.26 from Celgene Corporation
$396.45 from Genentech USA, Inc.
$395.31 from E.R. Squibb & Sons, L.L.C.
$280.47 from Horizon Pharma plc
$246.96 from LILLY USA, LLC
$246.47 from Purdue Pharma L.P.
$228.12 from GlaxoSmithKline, LLC.
$192.04 from UCB, Inc.
$132.03 from Mallinckrodt LLC
$116.66 from Regeneron Healthcare Solutions, Inc.
$87.29 from Endo Pharmaceuticals Inc.
$85.41 from Questcor Pharmaceuticals
$70.70 from Sobi, Inc
$40.24 from Iroko Pharmaceuticals, LLC
$32.12 from Radius Health, Inc.
Payments received by Dr. Anna Gramling, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!